Fingolimod, a drug used in multiple sclerosis, prevents memory problems in HD mice. Would it work in patients?
Antibodies are known for their role in immunity, but researchers repurpose them in many ways. Can they be used in HD?
Some unexpected findings suggest new ways to aim at an old target in HD
Raptor Pharmaceuticals announces intermediate results from a long-term study of cysteamine in Huntington's disease
A recent HD animal study reveals that a small molecule drug could be an effective “Trk” to target for HD therapeutics
Day 3 of CHDI’s HD therapeutics conference: growth factors and CHDI’s advanced therapies